RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients.

Carmeliet, P; Li, X; Treps, L; Conradi, L-C; Loges, S

Carmeliet, P; Li, X; Treps, L; Conradi, L-C; Loges, S.

Afiliação

Carmeliet P; State Key Laboratory of Ophthalmology (SKLO), Zhongshan Ophthalmic Center (ZOC), Sun Yat-Sen University, Guangzhou, P.R. China.
Li X; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), Leuven, Belgium.
Treps L; Laboratory of Angiogenesis and Vascular Metabolism, VIB Center for Cancer Biology, Leuven, Belgium.
Conradi LC; State Key Laboratory of Ophthalmology (SKLO), Zhongshan Ophthalmic Center (ZOC), Sun Yat-Sen University, Guangzhou, P.R. China.
Loges S; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), Leuven, Belgium.

Ann Oncol ; 29(3): 527-529, 2018 03 01.

Article em En | MEDLINE | ID: mdl-29360914

Assuntos

Anticorpos Monoclonais; Fator D de Crescimento do Endotélio Vascular; Anticorpos Monoclonais Humanizados; Biomarcadores; Método Duplo-Cego; Humanos; Ramucirumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator D de Crescimento do Endotélio Vascular / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Oncol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google